RxDoctor Payments Data
★ My doctorsLook up a doctor →

Raymond Schultz, MD

Plastic and Reconstructive Surgery · Williamsville, NYNPI 1124014824

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,934 of the $8,871 with a category attached, or 78.2%. 26 manufacturers reported payments, led by AbbVie at 30.0% of the total.

$8,871in general payments, 2019–2025

Across 213 payments — averaging $41.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Innovation Technologies Inc$2K
  • Polynovo North America LLC$599
  • W. L. Gore & Associates, Inc.$500
  • TELA Bio, Inc.$499
  • Integra Lifesciences Corporation$392
  • plus $2K from 20 others

What the payments were for

  • Speaking & faculty fees$5006%
  • Travel & lodging$1,39816%
  • Food & beverage$6,93478%
  • Education$380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)51$2,664
Innovation Technologies Inc40$2,154
Polynovo North America LLC34$599
W. L. Gore & Associates, Inc.1$500
TELA Bio, Inc.6$499
Integra Lifesciences Corporation7$392
Endo Pharmaceuticals Inc.10$390
Smith+Nephew11$315
Musculoskeletal Transplant Foundation Inc.9$248
KCI USA, Inc.2$186
Galderma Laboratories, L.p.2$126
Kowa Pharmaceuticals America, Inc.6$117
Organogenesis Inc.6$117
Medela LLC4$82
Merck5$80
Heron Therapeutics, Inc.4$70
Polymedics Innovations Inc.4$58
Endo USA, Inc.2$53
Solventum Corporation2$51
Sanara Medtech Inc.1$40
Convatec Inc.1$32
Kerecis Limited1$25
Medtronic1$24
Acera Surgical, Inc.1$20
Acelrx Pharmaceuticals, Inc.1$17
Davol Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,871 in reported general payments places this provider in the 80th percentile of 219 plastic and reconstructive surgery providers in New York.

See all plastic and reconstructive surgery providers in New York →

Medicare billing

Part B allowed, 2024
$32,847
Medicare patients
77
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$386
Cephalexin59$263
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$84
Clindamycin Hcl19$75
Amoxicillin14$50

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Williamsville

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →